PathomIQ Inc., headquartered in Silicon Valley ,USA, was founded by a team of outstanding biomarker discovery researchers, data scientists and clinicians with extensive experience in their areas of specialty.
Core Team
Rajat Roy
Serial Entrepreneur with two successful startup exits
Business and Technology Leader in Enterprise AI/ML applications and computing
George Wilding, MD
Former Vice Provost of Multidisciplinary Clinical Research, MD Anderson Cancer Center
Former Director, UW Carbone Cancer Center
Parag Jain
AI and High Performance Computing
Wei Huang, MD
Professor of Pathology, UW Carbone Cancer Center
Post Doctoral Fellow, Harvard / Brigham Women Hospital
Hirak Basu, PhD
Chair, DoD PCRP and NIH Study Sections
Former MD Anderson, UW Madison
Shivaani Kummar, MD
Chair of Cancer Research, OHSU/KCI
Co-Director of Center of Experimental Therapeutics, Knight Cancer center, ex Prof Stanford Medical and Yale
Ratnakar Malla
Former Software Executive at Oracle and Carta Healthcare
Cloud computing and enterprise scale software
Hassan Muhammad, PhD
Former Scientist, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine
Chao Feng, PhD
Former Scientist, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine
Scientific Advisory Board
Debashish Roychowdhury, MD
Former Sr VP, Head of Global Oncology Drug Development Sanofi, GSK, Eli Lilly
Ramandeep Randhawa, PhD
Stanford University, PhD
Janak Desai, MS, MCh, FRCS
Honorary member of German, UK & Japan Urological Society
Chris Parker
Former Chief Business Officer, Adella, Business Development and Commercialization Executive at Exact Sciences, GE Healthcare, Affymetrix